Ankle arthrodesis after failed total ankle replacement: a systematic review of the literature.

Published

Journal Article (Review)

As the number of total ankle replacements (TARs) performed has risen, so has the need for revision. The purpose of this investigation was to perform a systematic review of clinical outcomes following a salvage ankle arthrodesis from a failed TAR to identify patient- and technique-specific prognostic factors and to determine the clinical outcomes and complications following an ankle arthrodesis for a failed TAR.We searched PubMed, Medline, EMBASE, and the Cochrane Central Register of Controlled Trials for studies that analyzed ankle fusion after failed TAR with a minimum follow-up of 1 year.We included 16 studies (193 patients). The majority of patients (41%) underwent the index TAR for rheumatoid arthritis. The majority of these revision surgeries were secondary to component loosening, frequently of the talar component (38%). In the cases that were revised to an ankle arthrodesis, 81% fused after their first arthrodesis procedure. The intercalary bone graft group and the blade plate group had the highest rate of fusion after the first attempt at fusion at 100%, whereas the tibiotalocalcaneal fusion with cage group had the lowest fusion rate at 50%. The overall complication rate was 18.2%, whereas the overall nonunion rate was 10.6%.A salvage ankle arthrodesis for a failed TAR results in favorable clinical end points and overall satisfaction at short-term follow-up if the patients achieve fusion. The bone graft fusion and blade plate group resulted in the highest first-attempt fusion rate, with a low complication rate. Future studies should include prospective, comparative control or surgical groups and use standardized outcome measurements that will make direct comparisons easier.Level IV: Systematic Review of Level IV Studies.

Full Text

Duke Authors

Cited Authors

  • Gross, C; Erickson, BJ; Adams, SB; Parekh, SG

Published Date

  • April 2015

Published In

Volume / Issue

  • 8 / 2

Start / End Page

  • 143 - 151

PubMed ID

  • 25561701

Pubmed Central ID

  • 25561701

Electronic International Standard Serial Number (EISSN)

  • 1938-7636

International Standard Serial Number (ISSN)

  • 1938-6400

Digital Object Identifier (DOI)

  • 10.1177/1938640014565046

Language

  • eng